e-learning
resources
London 2016
Sunday, 04.09.2016
ME2 New treatment approaches for idiopathic pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New treatment approaches for IPF
Luca Richeldi (Southampton, United Kingdom)
Source:
International Congress 2016 – ME2 New treatment approaches for idiopathic pulmonary fibrosis
Session:
ME2 New treatment approaches for idiopathic pulmonary fibrosis
Session type:
Meet the expert
Number:
1421
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Luca Richeldi (Southampton, United Kingdom). New treatment approaches for IPF. International Congress 2016 – ME2 New treatment approaches for idiopathic pulmonary fibrosis
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
New treatment strategies in AATD
Source: Annual Congress 2013 –Alpha-1 antitrypsin deficiency and the lung: celebrating the 50th anniversary of its first description
Year: 2013
New treatment of IPF still unknown?
Source: ERS Live 2007
Year: 2007
New treatment approaches to diaphragmatic dysfunction in COPD
Source: International Congress 2017 – PG10 Dysfunction of the diaphragm
Year: 2017
New therapeutic strategies in BOS
Source: Annual Congress 2007 - Bronchiolitis obliterans syndrome (BOS) after lung transplantation: new kids on the block
Year: 2007
New cystic fibrosis therapy targets
Source: Research Seminar 2014 - Protein quality control in lung disease
Year: 2014
Novel treatments for IPF
Source: International Congress 2014 – ERS/NEJM joint lunchtime session "The changing landscape of idiopathic pulmonary fibrosis (IPF)"
Year: 2014
New mechanisms and targets in COPD
Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD
Year: 2014
New methods of the treatment efficacy evaluation at asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 131s
Year: 2003
New approaches for diagnosis and management of COPD
Source: Annual Congress 2010 - GOLD Update
Year: 2010
New approaches for evaluation of treatment effectiveness among patients with pulmonary TB under DOTS implemented conditions
Source: Eur Respir J 2002; 20: Suppl. 38, 368s
Year: 2002
New aspects of COPD ethiopathogenesis
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
New frontiers in the management of asthma
Source: International Congress 2017 – State of the art session: "Paediatric"
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept